IL6 and COVID-19: The blend significantly reduced pro-inflammatory cytokines, such as IL-6, while increasing anti-inflammatory IL-10, suggesting that it helps modulate cytokine levels and counteract the hyperactivation caused by SARS-CoV-2, potentially reducing COVID-19 progression and sequelae [76].